Petros Pharmaceuticals, Inc. Shareholders' Equity
Petros Pharmaceuticals, Inc. (PTPI) had Shareholders' Equity of $700.89 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $700.89K.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.77M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.87M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $3.37M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $700.89K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.77M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $2.87M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $3.37M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.45M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$9.58M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | -$7.47M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $3.12M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $8.07M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $9.79M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $12.07M 10-K · filed 2026-04-15 | |
| 2023-09-30 | $6.93M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $12.94M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $15.45M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $16.70M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $20.69M 10-Q · filed 2023-11-15 | |
| 2022-06-30 | $34.22M 10-Q · filed 2023-11-15 | |
| 2022-03-31 | $35.73M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $35.54M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $17.85M 10-Q/A · filed 2022-11-15 | |
| 2021-06-30 | $19.49M 10-Q/A · filed 2022-11-15 | |
| 2021-03-31 | $20.92M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $17.47M 10-K · filed 2023-03-31 | |
| 2020-09-30 | -$7.13M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$3.83M 10-Q · filed 2021-11-15 | -$3.83M 10-Q · filed 2021-08-16 |
| 2020-03-31 | $1.94M 10-Q · filed 2021-08-16 | $1.94M 10-Q · filed 2021-05-14 |
| 2019-12-31 | $8.02M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |